Keywords: Chelsea Thera, Micromet, Northera, Blinatumomab, Parkinson's disease, Leukemia, NOH

Chelsea and Micromet leap on strong clinical data for Northera and blinatumomab

Article | 13 June 2011

USA-based Chelsea Therapeutics International’s (Nasdaq: CHTP) shares soared 16% to $4.87 early Friday after analysts at Roth Capital tripled their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Micromet

Chelsea Therapeutics

Go to company listing

Related Drugs

blinatumomab

Northera

Go to drug listing